Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 FY- Text added to 2021 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abatement, ADCC, adenocarcinoma, adult, Antengene, argued, Arrowhead, belzutifan, Biotech, Biothera, bispecific, BVF, cervical, chemoradiation, Commerce, cytotoxicity, deep, depleting, digit, dismissed, distributor, Doce, dom, drove, ductal, durva, EMD, esophageal, etruma, exfiltrate, expeditiously, Exscientia, Fc, fear, gastric, hardware, hematologic, hematological, ID, imputed, instructed, insufficient, intermittently, inventory, Jacobio, jointly, judgement, mid, missed, myeloma, NiKang, nonrefundable, numerically, outperformed, PDAC, percentile, precursor, PSA, quemli, quemliclustat, rebounded, reclassed, refractory, rego, relapsed, repaid, repayment, Rescue, risen, SeaGen, Serono, Shanghai, slightly, stream, Teon, thought, Tpex, unamortized, unlock, unobservable, Unverified, vaccine, VHL, von, weekly, WELIREG, worsened, worsening, WT, zim
Removed:
activate, affinity, Appl, applying, bind, biochemical, blood, breast, built, Calithera, capitalize, contrast, display, dosed, driver, emerging, exhibited, explanation, exposing, formulated, highest, inappropriate, initiating, inseparable, insignificant, interaction, internalization, mg, molecular, opening, picomolar, potently, prefer, privately, rat, regular, shed, signal, signaling, solid, sublease, substrate, Subtopic, surface, transgenic, triple, unaudited, undergoing, vessel
Valuein 2020 FY filing- Value in 2021 FY filing
Original filings
Filing view